NeuroServo Press Releases

• Published on September 4, 2024 - 20:23 GMT

  

  NeuroServo appoints Dr Andrew J. Cole as Chief Medical Officer

  NeuroServo, developing an instant-use EEG with AI pathology assessment, announced that Dr Andrew Cole has been appointed Chief Medical Officer and board member. MONTREAL, QC, CANADA, September 4, 2024 /⁨EINPresswire.com⁩/ -- Dr. Andrew J. Cole is Director …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on August 26, 2024 - 11:00 GMT

  

  NeuroServo announced FDA 510K clearance for VEEGix, its instant-use EEG

  NeuroServo. is proud to announce that its innovative instant-use EEG has received U.S. Food and Drug Administration (FDA) clearance. MONTREAL, QC, CANADA, August 26, 2024 /⁨EINPresswire.com⁩/ -- VEEGix is an instant-use, compact, prefrontal EEG device …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on June 20, 2023 - 10:00 GMT

  

  NeuroServo (instant EEG for ICU and ER) announces closing of $2.2M funding round

  MONTREAL, QC, CANADA, June 20, 2023 /⁨EINPresswire.com⁩/ -- NeuroServo Inc., announced today the closing of a round of $2.2 million CAD that will be used to finance the commercialization of its medical innovation, an instant-use and miniaturized EEG ( …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...